{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:02:06Z","timestamp":1793754126117,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jtct.2023.08.028","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T12:12:50Z","timestamp":1693570370000},"page":"666-673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4086-6453","authenticated-orcid":false,"given":"Qaiser","family":"Bashir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0859-7257","authenticated-orcid":false,"given":"Marc","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tondre","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Chmielewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Janakiram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa A.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Romundstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad Z.","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8540-2364","authenticated-orcid":false,"given":"Kimberly","family":"Zwibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7394-5185","authenticated-orcid":false,"given":"Mohamed A.","family":"Kharfan-Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.08.028_bib0001","series-title":"Surveillance, Epidemiology, and End Results Program","year":"2022"},{"key":"10.1016\/j.jtct.2023.08.028_bib0002","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines: Multiple Myeloma. Version 1.2023. 2022. Available at: https:\/\/www.nccn.org\/guidelines\/. Accessed November 18, 2022."},{"key":"10.1016\/j.jtct.2023.08.028_bib0003","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2204925","article-title":"Triplet therapy, transplantation, and maintenance until progression in myeloma","volume":"387","author":"Richardson","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.08.028_bib0004","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.3390\/jcm11123541","article-title":"Complications of autologous stem cell transplantation in multiple myeloma: results from the CALM study","volume":"11","author":"Waszczuk-Gajda","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtct.2023.08.028_bib0005","unstructured":"Auletta JJ, Kou J, Chen M, Shaw BE. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides, 2021."},{"key":"10.1016\/j.jtct.2023.08.028_bib0006","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.jval.2018.04.125","article-title":"Real-life autologous stem cell transplantation and overall survival rates in newly diagnosed multiple myeloma patients: an analysis based on a German claims dataset","volume":"21","author":"Mueller","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.jtct.2023.08.028_bib0007","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jnci\/djy073","article-title":"Association between autologous stem cell transplant and survival among Californians with multiple myeloma","volume":"111","author":"Rosenberg","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtct.2023.08.028_bib0008","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1002\/cncr.30747","article-title":"Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: a CIBMTR report","volume":"123","author":"Schriber","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.08.028_bib0009","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1016\/j.clml.2020.11.013","article-title":"Multiple myeloma in Hispanics: incidence, characteristics, survival, results of discovery, and validation using real-world and Connect MM Registry data","volume":"21","author":"Kaur","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtct.2023.08.028_bib0010","doi-asserted-by":"crossref","first-page":"djv139","DOI":"10.1093\/jnci\/djv139","article-title":"The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma","volume":"107","author":"Winn","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtct.2023.08.028_bib0011","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1634\/theoncologist.2017-0478","article-title":"Cancer diagnosis: a trauma for patients and doctors alike","volume":"23","author":"Gieseler","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.jtct.2023.08.028_bib0012","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s13187-020-01882-3","article-title":"An iterative formative evaluation of medical education for multiple myeloma patients receiving autologous stem cell transplant","volume":"37","author":"Halpin","year":"2022","journal-title":"J Cancer Educ"},{"key":"10.1016\/j.jtct.2023.08.028_bib0013","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.3390\/curroncol29070358","article-title":"Quality of online information on multiple myeloma available for laypersons","volume":"29","author":"Staemmler","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jtct.2023.08.028_bib0014","unstructured":"Dieguez G, Ferro C, Rotter D. The cost burden of blood cancer care. A longitudinal analysis of commercially insured patients diagnosed with blood cancer. Milliman Research Report. Commissioned by The Leukemia and Lymphoma Society. October 2018."},{"key":"10.1016\/j.jtct.2023.08.028_bib0015","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.bbmt.2015.05.013","article-title":"Cost-effectiveness of autologous hematopoietic stem cell transplantation for elderly patients with multiple myeloma using the Surveillance, Epidemiology, and End Results-Medicare database","volume":"21","author":"Shah","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.028_bib0016","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/ctr.12421","article-title":"Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma","volume":"28","author":"Pandya","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jtct.2023.08.028_bib0017","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11912-019-0804-4","article-title":"Management of newly diagnosed elderly multiple myeloma patients","volume":"21","author":"Antoine-Pepeljugoski","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jtct.2023.08.028_bib0018","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/s41375-020-0876-z","article-title":"Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)","volume":"34","author":"Terpos","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.08.028_bib0019","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.2019000406","article-title":"With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study","volume":"133","author":"Fillmore","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.028_bib0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/bloodadvances.2017010512","article-title":"Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications","volume":"2","author":"Pulte","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.08.028_bib0021","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1182\/blood-2018-08-825349","article-title":"Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing","volume":"133","author":"Kumar","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.028_bib0022","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bbmt.2015.03.002","article-title":"Hematopoietic stem cell transplantation for multiple myeloma: guidelines from the American Society for Blood and Marrow Transplantation","volume":"21","author":"Shah","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.028_bib0023","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJMe1700453","article-title":"Transplantation for myeloma - now or later?","volume":"376","author":"Schiffer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.08.028_bib0024","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.bbmt.2018.04.007","article-title":"Analysis of clinical factors and outcomes associated with nonuse of collected peripheral blood stem cells for autologous stem cell transplants in transplant-eligible patients with multiple myeloma","volume":"24","author":"Kansagra","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.028_bib0025","first-page":"328","article-title":"Referral patterns and clinical outcomes for transplant-eligible lymphoma and myeloma patients evaluated at an urban county hospital","volume":"6","author":"Yun","year":"2016","journal-title":"J Stem Cell Res Ther"},{"key":"10.1016\/j.jtct.2023.08.028_bib0026","doi-asserted-by":"crossref","first-page":"e716","DOI":"10.1016\/j.clml.2022.03.013","article-title":"Prolonged lenalidomide induction does not significantly impair stem cell collection in multiple myeloma patients mobilized with cyclophosphamide or plerixafor: a report from the Covid era","volume":"22","author":"Rybinski","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtct.2023.08.028_bib0027","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/pon.5105","article-title":"Determinants of satisfactory patient communication and shared decision making in patients with multiple myeloma","volume":"28","author":"Nejati","year":"2019","journal-title":"Psychooncology"},{"key":"10.1016\/j.jtct.2023.08.028_bib0028","doi-asserted-by":"crossref","first-page":"e23354","DOI":"10.2196\/23354","article-title":"The effect of online health information seeking on physician-patient relationships: systematic review","volume":"24","author":"Luo","year":"2022","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.jtct.2023.08.028_bib0029","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.2196\/jmir.5729","article-title":"Internet health information seeking and the patient-physician relationship: a systematic review","volume":"19","author":"Tan","year":"2017","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.jtct.2023.08.028_bib0030","doi-asserted-by":"crossref","first-page":"e34790","DOI":"10.2196\/34790","article-title":"Online health information seeking behaviors among older adults: systematic scoping review","volume":"24","author":"Zhao","year":"2022","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.jtct.2023.08.028_bib0031","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41408-019-0205-9","article-title":"Current status of autologous stem cell transplantation for multiple myeloma","volume":"9","author":"Al Hamed","year":"2019","journal-title":"Blood Cancer J"},{"issue":"suppl 1)","key":"10.1016\/j.jtct.2023.08.028_bib0032","first-page":"S3","article-title":"Current approaches to management of newly diagnosed multiple myeloma","volume":"97","author":"Goel","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2023.08.028_bib0033","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2023.08.028_bib0034","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2023.08.028_bib0035","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/CCO.0000000000000783","article-title":"The role of autologous stem-cell transplantation in multiple myeloma in 2021","volume":"33","author":"Mina","year":"2021","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jtct.2023.08.028_bib0036","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.08.028_bib0037","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.pec.2019.04.028","article-title":"Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies","volume":"102","author":"LeBlanc","year":"2019","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jtct.2023.08.028_bib0038","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/1078155216639753","article-title":"Mixed outpatient-inpatient autologous stem cell transplant for multiple myeloma: a cost-saving initiative in a resource constrained environment","volume":"23","author":"Clemmons","year":"2017","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.jtct.2023.08.028_bib0039","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/SPC.0000000000000305","article-title":"Advances in delivery of ambulatory autologous stem cell transplantation for multiple myeloma","volume":"11","author":"Khouri","year":"2017","journal-title":"Curr Opin Support Palliat Care"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723015105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723015105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:09:35Z","timestamp":1763003375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723015105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2666636723015105"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.028","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}